MALLORY DIXON: Open Payments
NPI 1396224754 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,646 in 175 payments from 17 companies in 2025. Trend: 2023 $1,390 · 2024 $1,252 · 2025 $2,646
Food & beverage: $2,567Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $469 |
| Janssen Biotech, Inc. | 18 | $408 |
| Lilly USA, LLC | 15 | $326 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $248 |
| Ardelyx, Inc. | 14 | $193 |
| Aimmune Therapeutics, Inc. | 10 | $168 |
| Madrigal Pharmaceuticals | 8 | $148 |
| GENZYME CORPORATION | 6 | $147 |
| QOL Medical, LLC | 6 | $130 |
| Gilead Sciences, Inc. | 5 | $88 |
Products named: TREMFYA, RINVOQ, ENTYVIO, IBSRELA, OMVOH, REZDIFFRA, DUPIXENT, Sucraid.
Industry payments across TN — which companies pay providers there.
